Quality Improvement for Institutions
www.cvquality.acc.org

Cardiovascular Quality and Research News

ACC CV Quality SmartBrief

The ACC CV Quality SmartBrief eNewsletter is a free, twice-weekly briefing for health care stakeholders interested in quality care. Learn more about the ACC CV Quality SmartBrief and subscribe.

  • RSV more severe than flu for cancer patients, study finds

    A study in Open Forum Infectious Diseases found that respiratory syncytial virus infections tend to be more severe than influenza for hospitalized patients with malignancies. The study of 1,823 patients showed that RSV was associated with higher rates of intensive care unit admission and mortality. Researchers suggest that patients with cancer should be given priority for RSV vaccination. Infectious Disease Advisor (1/5) Learn More

  • Infection preventionists face funding, workforce challenges

    Members of an editorial advisory board predict 2026 will be a year of uncertainty and urgency for infection prevention and control professionals, driven by potential cuts to Agency for Healthcare Research and Quality funding, declining vaccination rates and workforce sustainability issues. However, there is optimism about the potential of artificial intelligence to reduce burden on health personnel. "Ultimate success will depend on whether health care leadership views IPC programs as liabilities to be cut or as strategic assets essential for future resilience and patient safety," said Brenna Doran of Innovative Partners Institute. Infection Control Today (1/2) Learn More

  • WHO's SARI definitions may miss true youth disease burden

    A recent systematic review published in JAMA Network Open showed that the World Health Organization's case definitions for severe acute respiratory infections may underestimate the true incidence of diseases like influenza and RSV in children. The study analyzed data from 13 studies across eight countries, showing that the WHO's 2014 SARI definition has reduced sensitivity and low specificity, particularly in children under the age of 5 years. This suggests that current surveillance systems might not accurately capture the disease burden, necessitating adjustments in incidence calculations. Center for Infectious Disease Research and Policy (12/30) Learn More

  • Semaglutide may reduce hospitalizations for some

    Semaglutide may reduce hospital admissions for patients at high cardiovascular risk who have overweight or obesity but not diabetes, according to a study in JAMA Cardiology. The study found semaglutide was associated with 18.3 admissions per 100 patient-years, compared with 20.4 for a placebo. The study included 17,604 patients. HealthDay News (1/2) Learn More

  • How hospital supply chain leaders can elevate their roles

    Hospital supply chain professionals see their roles evolving in the next five years from traditional procurement to enterprise strategy, leading cross-functional teams and technology integration. Leaders predict supply chain roles will be elevated to the C-suite, with deeper involvement in clinical strategy and value-based purchasing. Becker's Hospital Review (1/2) Learn More

  • AI in hospitals requires strong governance for safety

    AI has the potential to enhance hospital safety, but it cannot replace the essential cultural and leadership foundations required for a safety-first environment, according to Dr. Patsy McNeil of Adventist HealthCare. The organization emphasizes the need for strong AI governance, with a committee overseeing AI integration to ensure alignment with ethical standards and strategic objectives. Leadership plays a crucial role in fostering a culture that prioritizes safety and accountability, with AI serving as a tool to support these efforts rather than a stand-alone solution. Chief Healthcare Executive (12/29) Learn More

  • FDA approvals advanced women's health in 2025

    Important 2025 FDA approvals in women's health included gepotidacin for UTIs and gonorrhea, the Visby Medical Women's Sexual Health Test for at-home STI testing, Sonio Suspect AI for fetal anomaly detection, the Teal Wand for at-home cervical cancer screening, and elinzanetant for menopausal symptoms, according to a recent analysis. Other notable approvals include fosfomycin for complicated UTIs, zoliflodacin for gonorrhea, expanded use of flibanserin for hypoactive sexual desire disorder, and the Revi System for urgency urinary incontinence. Contemporary OB/GYN (1/1) Learn More

Temp Styles

American College of Cardiology: 2400 N St. NW, Washington DC 20006